{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:56:32Z","timestamp":1789721792491,"version":"4.0.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iCAN Digital Precision Cancer Medicine Flagship","award":["320185"],"award-info":[{"award-number":["320185"]}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["695727"],"award-info":[{"award-number":["695727"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["295693"],"award-info":[{"award-number":["295693"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["320149"],"award-info":[{"award-number":["320149"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["319083"],"award-info":[{"award-number":["319083"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["312041"],"award-info":[{"award-number":["312041"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["250345"],"award-info":[{"award-number":["250345"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["2021-02298"],"award-info":[{"award-number":["2021-02298"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Precision medicine carries great potential for management of all tumor types. The aim of this retrospective study was to investigate if the two most common genetically distinct uterine fibroid subclasses, driven by aberrations in MED12 and HMGA2 genes, respectively, influence response to treatment with the progesterone receptor modulator ulipristal acetate. Changes in diameter and mutation status were derived for 101 uterine fibroids surgically removed after ulipristal acetate treatment. A significant difference in treatment response between the two major subclasses was detected. MED12 mutant fibroids had 4.4 times higher odds of shrinking in response to ulipristal acetate treatment as compared to HMGA2 driven fibroids (95% confidence interval 1.37\u201313.9; P\u00a0=\u20090.013), and in a multivariate analysis molecular subclassification was an independent predictive factor. Compatible with this finding, gene expression and DNA methylation analyses revealed subclass specific differences in progesterone receptor signaling. The work provides a proof-of-principle that uterine fibroid treatment response is influenced by molecular subclass and that the genetic subclasses should be taken into account when evaluating current and future uterine fibroid therapies.<\/jats:p>","DOI":"10.1093\/hmg\/ddac217","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T21:29:49Z","timestamp":1661894989000},"page":"1063-1071","source":"Crossref","is-referenced-by-count":18,"title":["Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-3524","authenticated-orcid":false,"given":"\u00c5sa","family":"Kolterud","sequence":"first","affiliation":[{"name":"Karolinska Institutet Department of Biosciences and Nutrition, , 141 83 Huddinge , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"V\u00e4lim\u00e4ki","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Kuisma","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonatan","family":"Patomo","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini T","family":"Ilves","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netta","family":"M\u00e4kinen","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Kaukomaa","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Palin","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"},{"name":"University of Helsinki iCAN Digital Precision Cancer Medicine Flagship, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eevi","family":"Kaasinen","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auli","family":"Karhu","sequence":"additional","affiliation":[{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annukka","family":"Pasanen","sequence":"additional","affiliation":[{"name":"University of Helsinki and HUSLAB, Helsinki University Hospital Department of Pathology, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"B\u00fctzow","sequence":"additional","affiliation":[{"name":"University of Helsinki and HUSLAB, Helsinki University Hospital Department of Pathology, , 00290 Helsinki , Finland"},{"name":"University of Helsinki and Helsinki University Hospital Department of Obstetrics and Gynecology, , 00029 HUS\u00a0Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskari","family":"Heikinheimo","sequence":"additional","affiliation":[{"name":"University of Helsinki and Helsinki University Hospital Department of Obstetrics and Gynecology, , 00029 HUS\u00a0Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Kopp Kallner","sequence":"additional","affiliation":[{"name":"Danderyd Hospital, Karolinska Institutet, Department of Clinical Sciences, \u00a0 171 77 Stockholm , Sweden"},{"name":"Danderyd Hospital Department of Obstetrics and Gynecology, , 182 88 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri A","family":"Aaltonen","sequence":"additional","affiliation":[{"name":"Karolinska Institutet Department of Biosciences and Nutrition, , 141 83 Huddinge , Sweden"},{"name":"University of Helsinki Department of Medical and Clinical Genetics, University of Helsinki; Applied Tumor Genomics Research Program, Research Programs Unit, , 00290 Helsinki , Finland"},{"name":"University of Helsinki iCAN Digital Precision Cancer Medicine Flagship, , 00290 Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","article-title":"Genomics of uterine leiomyomas: insights from high-throughput sequencing","volume":"102","author":"Mehine","year":"2014","journal-title":"Fertil. Steril."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03747-1","article-title":"Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma","volume":"596","author":"Berta","year":"2021","journal-title":"Nature"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"M\u00e4kinen","year":"2011","journal-title":"Science"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng0895-436","article-title":"Recurrent rearrangements in the high-mobility group protein gene, Hmgi-C, in benign mesenchymal tumors","volume":"10","author":"Schoenmakers","year":"1995","journal-title":"Nat. Genet."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0301-2115(98)00204-8","article-title":"Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes","volume":"81","author":"Van de Ven","year":"1998","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","article-title":"Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors","volume":"164","author":"Lehtonen","year":"2004","journal-title":"Am. J. Pathol."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/molehr\/5.12.1150","article-title":"Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells","volume":"5","author":"Hennig","year":"1999","journal-title":"Mol. Hum. Reprod."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.fertnstert.2020.05.036","article-title":"HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma","volume":"114","author":"Li","year":"2020","journal-title":"Fertil. Steril."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41598-017-01199-0","article-title":"Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas","volume":"7","author":"Heinonen","year":"2017","journal-title":"Sci. Rep."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil. Steril."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5468\/ogs.2017.60.1.69","article-title":"Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist","volume":"60","author":"Lee","year":"2017","journal-title":"Obstet. Gynecol. Sci."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.rbmo.2019.07.028","article-title":"Predictors of uterine fibroid volume reduction under ulipristal acetate: a prospective MRI study","volume":"39","author":"Netter","year":"2019","journal-title":"Reprod. BioMed. Online"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00404-020-05918-3","article-title":"What happens after randomised controlled trials? Uterine fibroids and ulipristal acetate: systematic review and meta-analysis of \"real-world\" data","volume":"303","author":"Shah","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","volume":"105","author":"Donnez","year":"2016","journal-title":"Fertil. Steril."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.fertnstert.2014.06.040","article-title":"MED12 mutation frequency in unselected sporadic uterine leiomyomas","volume":"102","author":"Heinonen","year":"2014","journal-title":"Fertil. Steril."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.humpath.2018.09.012","article-title":"Hydropic leiomyoma: a distinct variant of leiomyoma closely related to HMGA2 overexpression","volume":"84","author":"Griffin","year":"2019","journal-title":"Hum. Pathol."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","article-title":"In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment","volume":"104","author":"Courtoy","year":"2015","journal-title":"Fertil. Steril."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1933719117728802","article-title":"Ulipristal acetate and extracellular matrix production in human leiomyomas in vivo: a laboratory analysis of a randomized placebo controlled trial","volume":"25","author":"Cox","year":"2018","journal-title":"Reprod. Sci."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2004-1569","article-title":"Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5 '-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells","volume":"90","author":"Xu","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.stemcr.2021.07.013","article-title":"Progesterone receptor-DNA methylation crosstalk regulates depletion of uterine leiomyoma stem cells: a potential therapeutic target","volume":"16","author":"Liu","year":"2021","journal-title":"Stem Cell Rep."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.rbmo.2018.04.050","article-title":"Gene expression changes in uterine myomas in response to ulipristal acetate treatment","volume":"37","author":"Courtoy","year":"2018","journal-title":"Reprod. BioMed. Online"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/ijerph17030798","article-title":"Predictive factors of response to selective progesterone receptor modulator (ulipristal acetate) in the pharmacological treatment of uterine fibroids","volume":"17","author":"Szyd\u0142owska","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41388-018-0612-6","article-title":"Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/PAS.0000000000000569","article-title":"Apoplectic leiomyomas a morphologic analysis of 100 cases highlighting unusual features","volume":"40","author":"Bennett","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1038\/s41598-019-45839-z","article-title":"The ENCODE blacklist: identification of problematic regions of the genome","volume":"9","author":"Amemiya","year":"2019","journal-title":"Sci. Rep."},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature10730","article-title":"Differential oestrogen receptor binding is associated with clinical outcome in breast cancer","volume":"481","author":"Ross-Innes","year":"2012","journal-title":"Nature"},{"key":"2023032011063749600_","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nmeth.4184","article-title":"Detecting DNA cytosine methylation using nanopore sequencing","volume":"14","author":"Simpson","year":"2017","journal-title":"Nat. Methods"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hmg\/advance-article-pdf\/doi\/10.1093\/hmg\/ddac217\/46360314\/ddac217.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/32\/7\/1063\/49562155\/ddac217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/32\/7\/1063\/49562155\/ddac217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T09:32:27Z","timestamp":1700991147000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/32\/7\/1063\/6682816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,9,1]]},"published-print":{"date-parts":[[2023,3,20]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddac217","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,9,1]]}}}